Uncategorized
Leading Ophthalmologists Presented Real World Clinical Outcomes on Oraya Therapy for Wet AMD at EURETINA 15th Congress
NEWARK, Calif., & NICE, France--(BUSINESS WIRE)--Oraya Therapeutics Inc. announced today that leading ophthalmologists from three European countries presented patient results following one year after a single treatment with Oraya Therapy for wet age-related macular degeneration (AMD), during a symposium at the European Society of Retina Specialists' 15th Congress in Nice, France. The results show that Oraya Therapy is effective in maintaining vision with reduced injections for patients at diffe
